WuXi AppTec defends against 'blanket allegations' as US legislation casts shadow over certain Chinese drugmakers
Fierce Pharma
FEBRUARY 5, 2024
As new legislation stands to threaten the U.S. business of certain Chinese biopharma companies, CDMO giant WuXi AppTec has stepped in to make a case for itself. |
Let's personalize your content